Exercise is still recommended for those who are overweight, but the study suggests a vitamin C supplement can help those patients who can't or won't pursue activity.
Exercised is advised for overweight or obese patients, but if they can’t or won’t, supplements of vitamin C may do the job, according to new study.
Research presented at the 14th International Conference on Endothelin: Physiology, Pathophysiology and Therapeutics found that taking daily doses of vitamin C can provide similar cardiovascular benefits as exercise in adults who are overweight. According to the authors, about 50% of overweight and obese adults do not exercise as advised.
The study, conducted at the University of Colorado, examined the effect of vitamin C supplements on the protein endothelin (ET-1), which constricts blood vessels and is elevated in adults who are overweight. Vitamin C is known to improve blood vessel function, so the researchers wanted to measure whether it would lower ET-1 activity as well.
Led by Caitlin Dow, PhD, the team found that daily doses of vitamin C (500 mg) lowered ET-1 blood vessel constriction as much as daily walking, which could help reduce vascular risk.
The study evaluated 35 sedentary adults, whose blood vessels all showed signs of vasoconstriction. Of the group, 20 adults with an average body mass index or BMI 31 kg/m2 completed a 3-month course of treatment with time-released vitamin C, while 15 with an average BMI 29 kg/m2 completed regular walks for the same period. (The CDC considers a BMI of 25 to 29.9 to be overweight, while 30 and higher is obese.)
Researchers then measured ET-1 activity in forearm blood flow, and found that daily doses of vitamin C had a similarly positive effect on blood vessel constriction as walking.
While it would be preferable for overweight obese persons to exercise, supplements of vitamin C are a method to address a lack of exercise in those who do not, the researchers concluded.
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Contributor: The Diabetes Vendor Resource Guide—A Useful Directory for Employers
November 13th 2024Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and preventing complications, all while maintaining their professional responsibilities. This condition can lead to increased absenteeism, reduced productivity, and rising health care costs.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen